<> <http://www.w3.org/2000/01/rdf-schema#comment> "The repository administrator has not yet configured an RDF license."^^<http://www.w3.org/2001/XMLSchema#string> .
<> <http://xmlns.com/foaf/0.1/primaryTopic> <https://arxiv.universalpublishings.com/id/eprint/51878> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/AcademicArticle> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://purl.org/dc/terms/title> "PROSPECTS OF PHARMACOLOGICAL TREATMENT OF VASCULAR DEMENTIA IN PATIENTS WITH ARTERIAL HYPERTENSION"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://purl.org/ontology/bibo/abstract> "The article presents research data from 60 patients with vascular dementia. All subjects were divided into 2 groups: 1st group - 30 patients who received choline alfoscerate on the background of basic therapy; and group 2 - 30 patients who received only basic therapy. The effectiveness of therapy was evaluated twice: before treatment and on day 40 of treatment. The status was assessed using the VAS scale (visual-analogue scale for pain), according to the questionnaire for identifying vegetative disorders and determining the vegetative dystonia syndrome (VDS), according to the severity of vegetative reactivity according to the Danyini-Ashner test, and the Hamilton anxiety and depression test. A reliable nootropic effect of the drug was revealed, as well as its effect on cerebrosthenic and somatovegetative manifestations. There were no serious adverse events requiring additional measures."^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://purl.org/dc/terms/date> "2026-02-07" .
<https://arxiv.universalpublishings.com/id/org/ext-dbed9f2336796bf48bec732d36c8b42e> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Organization> .
<https://arxiv.universalpublishings.com/id/org/ext-dbed9f2336796bf48bec732d36c8b42e> <http://xmlns.com/foaf/0.1/name> "South Aral Region Medical Journal"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://purl.org/dc/terms/publisher> <https://arxiv.universalpublishings.com/id/org/ext-dbed9f2336796bf48bec732d36c8b42e> .
<https://arxiv.universalpublishings.com/id/publication/ext-dbed9f2336796bf48bec732d36c8b42e> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Collection> .
<https://arxiv.universalpublishings.com/id/publication/ext-dbed9f2336796bf48bec732d36c8b42e> <http://xmlns.com/foaf/0.1/name> "South Aral Region Medical Journal"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://purl.org/dc/terms/isPartOf> <https://arxiv.universalpublishings.com/id/publication/ext-dbed9f2336796bf48bec732d36c8b42e> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://purl.org/ontology/bibo/status> <http://purl.org/ontology/bibo/status/published> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://purl.org/dc/terms/creator> <https://arxiv.universalpublishings.com/id/person/ext-f40ca4cf98df300617cfd79e588bb46a> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://purl.org/ontology/bibo/authorList> <https://arxiv.universalpublishings.com/id/eprint/51878#authors> .
<https://arxiv.universalpublishings.com/id/eprint/51878#authors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#_1> <https://arxiv.universalpublishings.com/id/person/ext-f40ca4cf98df300617cfd79e588bb46a> .
<https://arxiv.universalpublishings.com/id/person/ext-f40ca4cf98df300617cfd79e588bb46a> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://arxiv.universalpublishings.com/id/person/ext-f40ca4cf98df300617cfd79e588bb46a> <http://xmlns.com/foaf/0.1/givenName> "Muzaffar"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-f40ca4cf98df300617cfd79e588bb46a> <http://xmlns.com/foaf/0.1/familyName> "Zokirov"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-f40ca4cf98df300617cfd79e588bb46a> <http://xmlns.com/foaf/0.1/name> "Muzaffar Zokirov"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://eprints.org/ontology/EPrint> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://eprints.org/ontology/ArticleEPrint> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://purl.org/dc/terms/isPartOf> <https://arxiv.universalpublishings.com/id/repository> .
<https://arxiv.universalpublishings.com/id/eprint/51878> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <https://arxiv.universalpublishings.com/id/eprint/51878/> .
<https://arxiv.universalpublishings.com/id/eprint/51878/> <http://purl.org/dc/elements/1.1/title> "HTML Summary of #51878 \n\nPROSPECTS OF PHARMACOLOGICAL TREATMENT OF VASCULAR DEMENTIA IN PATIENTS WITH ARTERIAL HYPERTENSION\n\n" .
<https://arxiv.universalpublishings.com/id/eprint/51878/> <http://purl.org/dc/elements/1.1/format> "text/html" .
<https://arxiv.universalpublishings.com/id/eprint/51878/> <http://xmlns.com/foaf/0.1/primaryTopic> <https://arxiv.universalpublishings.com/id/eprint/51878> .